In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
Molecules · 2023
DOI: 10.3390/molecules28145320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Menghan Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Science…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Promotion Program of Shandong First Medical University.
Abstract (Originalsprache)
The COVID-19 pandemic has caused severe health threat globally, and novel SARS-Cov-2 inhibitors are urgently needed for antiviral treatment. The main protease (Mpro) of the virus is one of the most effective and conserved targets for anti-SARS-CoV-2 drug development. In this study, we utilized a molecular docking-based virtual screening approach against the conserved catalytic site to identify small-molecule inhibitors of SARS-CoV-2 Mpro. Further biological evaluation helped us identify two compounds, AF-399/40713777 and AI-942/42301830, with moderate inhibitory activity. Besides that, the in silico data, including molecular dynamics (MD) simulation, binding free energy calculations, and AMDET profiles, suggested that these two hits could serve as the starting point for the future development of COVID-19 intervention treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan 250117, China.
- NHC Key Laboratory of Biotechnology Drugs, Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan 250117, China.
- Key Lab for Rare & Uncommon Diseases of Shandong Province, 6699 Qingdao Road, Jinan 250117, China.
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012, China.
ORCID-Profile: Dongwei Kang, Na Liu, Yanna Liu
Förderung
- Academic Promotion Program of Shandong First Medical University
Zitieren
APA
Gao, M., Kang, D., Liu, N., & Liu, Y. (2023). In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease. Molecules. https://doi.org/10.3390/molecules28145320
Vancouver
Gao M, Kang D, Liu N, Liu Y. In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease. Molecules. 2023. doi:10.3390/molecules28145320
BibTeX
@article{Gao2023,
author = {Gao, Menghan and Kang, Dongwei and Liu, Na and Liu, Yanna},
title = {In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28145320}
}
EUVIMED